545 related articles for article (PubMed ID: 26278220)
1. Progress in adjuvant chemotherapy for breast cancer: an overview.
Anampa J; Makower D; Sparano JA
BMC Med; 2015 Aug; 13():195. PubMed ID: 26278220
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
3. The curability of breast cancer and the treatment of advanced disease.
Guarneri V; Conte PF
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
[TBL] [Abstract][Full Text] [Related]
4. [Adjuvant chemotherapy of early stage breast cancer].
Boér K
Orv Hetil; 2010 Feb; 151(9):344-53. PubMed ID: 20159750
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy in early breast cancer.
Ejlertsen B
Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic era.
Colozza M; de Azambuja E; Cardoso F; Bernard C; Piccart MJ
Oncologist; 2006 Feb; 11(2):111-25. PubMed ID: 16476832
[TBL] [Abstract][Full Text] [Related]
7. [Adjuvant chemotherapy in hormone-receptor positive HER2-negative early breast cancer].
Lopez M; Di Lauro L; Viola G; Foggi P; Conti F; Corsetti S; Sergi D; Botti C; Di Filippo F; Vici P
Clin Ter; 2009; 160(6):481-8. PubMed ID: 20198292
[TBL] [Abstract][Full Text] [Related]
8. Progress in systemic adjuvant therapy of early-stage breast cancer.
Gradishar WJ; O'Regan RM
Int J Clin Oncol; 2003 Aug; 8(4):239-47. PubMed ID: 12955580
[TBL] [Abstract][Full Text] [Related]
9. [The use of adjuvant chemotherapy in stage II breast cancer in the last 25 years--a brief review].
Sulkes A
Harefuah; 2002 Apr; 141(4):374-8, 408. PubMed ID: 12017895
[TBL] [Abstract][Full Text] [Related]
10. [Evolution of adjuvant chemotherapy of breast cancer from Bonadonna to the taxanes].
Nagykálnai T
Magy Onkol; 2002; 46(4):307-13. PubMed ID: 12563352
[TBL] [Abstract][Full Text] [Related]
11. HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.
Gennari A; Sormani MP; Pronzato P; Puntoni M; Colozza M; Pfeffer U; Bruzzi P
J Natl Cancer Inst; 2008 Jan; 100(1):14-20. PubMed ID: 18159072
[TBL] [Abstract][Full Text] [Related]
12. Systemic Therapies for Nonmetastatic Breast Cancer: The Role of Neoadjuvant and Adjuvant Chemotherapy and the Use of Endocrine Therapy.
Bychkovsky BL; Dizon DS; Sikov WM
Clin Obstet Gynecol; 2016 Dec; 59(4):756-771. PubMed ID: 27741213
[TBL] [Abstract][Full Text] [Related]
13. Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays.
Albain KS; Paik S; van't Veer L
Breast; 2009 Oct; 18 Suppl 3():S141-5. PubMed ID: 19914534
[TBL] [Abstract][Full Text] [Related]
14. Prevention of breast cancer recurrence with adjuvant cytotoxic or endocrine therapy.
Rutqvist LE
Med Oncol Tumor Pharmacother; 1991; 8(3):163-8. PubMed ID: 1803176
[TBL] [Abstract][Full Text] [Related]
15. Extended adjuvant chemotherapy in endocrine non-responsive disease.
Colleoni M; Munzone E
Breast; 2013 Aug; 22 Suppl 2():S161-4. PubMed ID: 24074780
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant chemotherapy in primary carcinoma of the breast].
Harbeck N
Zentralbl Gynakol; 2003 Sep; 125(9):322-6. PubMed ID: 14569511
[TBL] [Abstract][Full Text] [Related]
17. Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2-positive breast cancers.
Musolino A; Boggiani D; Sikokis A; Rimanti A; Pellegrino B; Vattiato R; Sgargi P; Falcini F; Caminiti C; Michiara M; Leonardi F
Cancer Treat Rev; 2016 Feb; 43():1-7. PubMed ID: 26827687
[TBL] [Abstract][Full Text] [Related]
18. HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data.
Di Leo A; Desmedt C; Bartlett JM; Piette F; Ejlertsen B; Pritchard KI; Larsimont D; Poole C; Isola J; Earl H; Mouridsen H; O'Malley FP; Cardoso F; Tanner M; Munro A; Twelves CJ; Sotiriou C; Shepherd L; Cameron D; Piccart MJ; Buyse M;
Lancet Oncol; 2011 Nov; 12(12):1134-42. PubMed ID: 21917518
[TBL] [Abstract][Full Text] [Related]
19. Current status of taxanes as adjuvant therapy for early-stage breast cancer.
Wolff AC
Int J Fertil Womens Med; 2005; 50(5 Pt 1):227-9. PubMed ID: 16468473
[TBL] [Abstract][Full Text] [Related]
20. [New combination chemotherapy regimens in the primary treatment of operable breast cancer].
Conti F; Sergi D; Foggi P; Abbate MI; Lopez M
Clin Ter; 2007; 158(1):55-75. PubMed ID: 17405660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
